vs

Side-by-side financial comparison of Five Point Holdings, LLC (FPH) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

Sol-Gel Technologies Ltd. is the larger business by last-quarter revenue ($17.3M vs $13.6M, roughly 1.3× Five Point Holdings, LLC). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs -16.4%, a 83.7% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 3.2%).

Five Point Holdings, LLC is a leading U.S. real estate development company that focuses on planning and constructing large-scale master-planned mixed-use communities in high-demand markets across California. Its projects integrate residential housing, commercial office spaces, retail outlets, public amenities and recreational facilities to build vibrant, sustainable living and working environments for local populations.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

FPH vs SLGL — Head-to-Head

Bigger by revenue
SLGL
SLGL
1.3× larger
SLGL
$17.3M
$13.6M
FPH
Growing faster (revenue YoY)
SLGL
SLGL
+214.5% gap
SLGL
217.7%
3.2%
FPH
Higher net margin
SLGL
SLGL
83.7% more per $
SLGL
67.3%
-16.4%
FPH

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
FPH
FPH
SLGL
SLGL
Revenue
$13.6M
$17.3M
Net Profit
$-2.2M
$11.6M
Gross Margin
Operating Margin
-43.5%
65.1%
Net Margin
-16.4%
67.3%
Revenue YoY
3.2%
217.7%
Net Profit YoY
-109.6%
487.6%
EPS (diluted)
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FPH
FPH
SLGL
SLGL
Q1 26
$13.6M
Q4 25
$75.9M
Q3 25
$13.5M
Q2 25
$7.5M
$17.3M
Q1 25
$13.2M
Q4 24
$159.8M
Q3 24
$17.0M
Q2 24
$51.2M
$5.4M
Net Profit
FPH
FPH
SLGL
SLGL
Q1 26
$-2.2M
Q4 25
$58.7M
Q3 25
$21.1M
Q2 25
$3.3M
$11.6M
Q1 25
$23.3M
Q4 24
$121.0M
Q3 24
$4.8M
Q2 24
$14.7M
$2.0M
Operating Margin
FPH
FPH
SLGL
SLGL
Q1 26
-43.5%
Q4 25
89.0%
Q3 25
Q2 25
65.1%
Q1 25
Q4 24
87.5%
Q3 24
83.6%
Q2 24
86.1%
29.9%
Net Margin
FPH
FPH
SLGL
SLGL
Q1 26
-16.4%
Q4 25
77.3%
Q3 25
156.2%
Q2 25
44.4%
67.3%
Q1 25
177.0%
Q4 24
75.7%
Q3 24
28.0%
Q2 24
28.8%
36.4%
EPS (diluted)
FPH
FPH
SLGL
SLGL
Q1 26
Q4 25
Q3 25
Q2 25
$4.17
Q1 25
Q4 24
Q3 24
Q2 24
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FPH
FPH
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$332.6M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$31.9M
Total Assets
$3.2B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FPH
FPH
SLGL
SLGL
Q1 26
$332.6M
Q4 25
$425.5M
Q3 25
$351.1M
Q2 25
$456.6M
$24.3M
Q1 25
$528.3M
Q4 24
$430.9M
Q3 24
$224.5M
Q2 24
$217.4M
$26.5M
Stockholders' Equity
FPH
FPH
SLGL
SLGL
Q1 26
$2.3B
Q4 25
$2.3B
Q3 25
$2.3B
Q2 25
$2.2B
$31.9M
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.0B
Q2 24
$2.0B
$34.9M
Total Assets
FPH
FPH
SLGL
SLGL
Q1 26
$3.2B
Q4 25
$3.2B
Q3 25
$3.2B
Q2 25
$3.2B
$39.3M
Q1 25
$3.2B
Q4 24
$3.1B
Q3 24
$2.9B
Q2 24
$2.9B
$42.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FPH
FPH
SLGL
SLGL
Operating Cash FlowLast quarter
$-44.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FPH
FPH
SLGL
SLGL
Q1 26
$-44.5M
Q4 25
$105.2M
Q3 25
$40.4M
Q2 25
$-71.6M
Q1 25
$56.7M
Q4 24
$116.0M
Q3 24
$-18.0M
Q2 24
$-23.2M
Free Cash Flow
FPH
FPH
SLGL
SLGL
Q1 26
Q4 25
$105.0M
Q3 25
Q2 25
$-71.7M
Q1 25
$56.7M
Q4 24
$115.2M
Q3 24
$-18.2M
Q2 24
$-23.6M
FCF Margin
FPH
FPH
SLGL
SLGL
Q1 26
Q4 25
138.4%
Q3 25
Q2 25
-959.3%
Q1 25
430.9%
Q4 24
72.1%
Q3 24
-106.9%
Q2 24
-46.1%
Capex Intensity
FPH
FPH
SLGL
SLGL
Q1 26
0.0%
Q4 25
0.3%
Q3 25
0.0%
Q2 25
0.8%
Q1 25
0.3%
Q4 24
0.5%
Q3 24
1.3%
Q2 24
0.7%
Cash Conversion
FPH
FPH
SLGL
SLGL
Q1 26
Q4 25
1.79×
Q3 25
1.92×
Q2 25
-21.58×
Q1 25
2.44×
Q4 24
0.96×
Q3 24
-3.77×
Q2 24
-1.58×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons